| [1] |
Scientific Document Group ESC. [2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death][J]. G Ital Cardiol(Rome), 2023, 24(3 Suppl 1):e1-e132.
|
| [2] |
Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease[J]. Circulation, 2012, 125(8):1043-1052.
|
| [3] |
中国心脏骤停与心肺复苏报告编写组, 徐峰, 陈玉国. 中国心脏骤停与心肺复苏报告(2022年版)概要[J]. 中国循环杂志, 2023, 38(10):1005-1017.
|
| [4] |
赵智梅, 陈晓松, 杨仪君, 等. 我国5516例尸体猝死病例流行特征分析[J]. 中国急救医学, 2020, 40(2):158-163.
|
| [5] |
Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac arrest[J]. Am J Cardiol, 2004, 93(12):1455-1460.
|
| [6] |
Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction,heart failure, or both[J]. N Engl J Med, 2005, 352(25):2581-2588.
|
| [7] |
林志彬, 邓运生, 杨京山, 等. 心力衰竭室性心律失常与心脏性猝死的研究及治疗进展[J/OL]. 中华心脏与心律电子杂志, 2022, 10(3):147-150.
|
| [8] |
Holmström L, Juntunen S, Vähätalo J, et al. Plaque histology and myocardial disease in sudden coronary death:the Fingesture study[J]. Eur Heart J, 2022, 43(47):4923-4930.
|
| [9] |
Vähätalo J, Holmström L, Pakanen L, et al. Coronary artery disease as the cause of sudden cardiac death among victims<50 years of age[J]. Am J Cardiol, 2021, 147:33-38.
|
| [10] |
Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart[J]. Circulation, 2000, 102(6):649-654.
|
| [11] |
Marijon E, Narayanan K, Smith K, et al. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action[J]. Lancet, 2023, 402(10405):883-936.
|
| [12] |
Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. the cardiac arrhythmia suppression trial[J]. N Engl J Med, 1991, 324(12):781-788.
|
| [13] |
Piccini JP, Berger JS, O'Connor CM. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials[J]. Eur Heart J, 2009, 30(10):1245-1253.
|
| [14] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会, 等. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10):760-789.
|
| [15] |
McDonagh TA, Metra M,Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42(36):3599-3726.
|
| [16] |
Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy[J]. N Engl J Med, 2007, 357(26):2657-2665.
|
| [17] |
Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short-and long-term outcomes in a prospective single-center study[J]. Circulation, 2008, 117(4):462-469.
|
| [18] |
Komatsu Y, Hocini M, Nogami A, et al. Catheter aablation of refractory ventricular fibrillation storm after myocardial infarction[J]. Circulation, 2019, 139(20):2315-2325.
|
| [19] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 植入型心律转复除颤器临床应用中国专家共识(2021)[J]. 中华心律失常学杂志, 2018, 46(10):760-789.
|
| [20] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会, 等. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10):760-789.
|